基线CT影像组学特征预测晚期食管鳞状细胞癌接受紫杉醇联合顺铂新辅助化疗后病理完全缓解
研究纳入两家医院326例晚期食管鳞状细胞癌患者,基线增强CT后接受紫杉醇联合顺铂新辅助化疗,其中115例达病理完全缓解、211例未达。筛选8个影像组学特征建模,支持向量机模型在训练、测试及外部验证队列的AUC分别为0.929、0.868、0.866。
要点
- 基线胸部增强CT可提取影像组学特征用于预测晚期食管鳞癌新辅助化疗后病理完全缓解。
- 支持向量机模型表现最佳,训练、测试和外部验证队列AUC分别为0.929、0.868和0.866。
- 校准曲线和Brier评分提示模型拟合良好且预测准确性较高。
核心结论
- CT影像组学模型有助于预测晚期食管鳞状细胞癌的病理完全缓解,支持向量机模型可作为合适的预测模型。
研究设计与样本
- 多中心研究,纳入两家医院326例连续晚期食管鳞状细胞癌患者,基线胸部增强CT后接受紫杉醇联合顺铂新辅助化疗;第1家医院271例随机分为训练队列188例和测试队列83例,第2家医院55例作为外部验证队列;以病理完全缓解为参考标准。
关键影像表现/征象
- 在基线胸部增强CT上勾画感兴趣区,经最小绝对收缩和选择算子降维生成有用影像组学特征。
- 共筛选出8个与晚期食管鳞状细胞癌病理完全缓解相关的影像组学特征用于建模。
诊断标准与关键数值
- 8个影像组学特征在训练队列和测试队列中与病理完全缓解相关,P值均<0.01。
- 支持向量机模型在训练队列AUC为0.929、F-1评分为0.857。
- 支持向量机模型在测试队列AUC为0.868、F-1评分为0.847。
- 支持向量机模型在外部验证队列AUC为0.866、F-1评分为0.737。
临床应用与阅片要点
- 可在基线胸部增强CT上勾画感兴趣区提取影像组学特征,辅助预测晚期食管鳞状细胞癌新辅助化疗后的病理完全缓解。
- 原文结论认为支持向量机模型可作为合适的预测模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop a CT radiomics model to predict pathological complete response (pCR) of advanced esophageal squamous cell carcinoma (ESCC) toneoadjuvant chemotherapy using paclitaxel and cisplatin.
MATERIALS AND METHODS: 326 consecutive patients with advanced ESCC from two hospitals undergoing baseline contrast-enhanced CT followed by neoadjuvant chemotherapy using paclitaxel and cisplatin were enrolled, including 115 patients achieving pCR and 211 patients without pCR. Of the 271 cases from 1st hospital, 188 and 83 cases were randomly allocated to the training and test cohorts, respectively. The 55 patients from a second hospital were assigned as an external validation cohort. Region of interest was segmented on the baseline thoracic contrast-enhanced CT. Useful radiomics features were generated by dimension reduction using least absolute shrinkage and selection operator. The optimal radiomics features were chosen using support vector machine (SVM). Discriminating performance was assessed with area under the receiver operating characteristic curve (ROC) and F-1score. The calibration curves and Brier score were used to evaluate the predictive accuracy.
RESULTS: Eight radiomics features were selected to create radiomics models related to pCR of advanced ESCC (P-values < 0.01 for both the training and test cohorts). SVM model showed the best performance (AUCs = 0.929, 0.868 and 0.866, F-1scores = 0.857, 0.847 and 0.737 in the training, test and external validation cohorts, respectively). The calibration curves and Brier scores indicated goodness-of-fit and its great predictive accuracy.
CONCLUSION: CT radiomics models could well help predict pCR of advanced ESCC, and SVM model could be a suitable predictive model.
引用
- Ou J, Zhou HY, Qin HL, et al. Baseline CT radiomics features to predict pathological complete response of advanced esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy using paclitaxel and cisplatin. Eur J Radiol. 2024. PMID: 39341168. doi:10.1016/j.ejrad.2024.111763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。